GLP1R and ADan amyloidosis: The transcriptional profiling of GLP-1 receptor blockade in EcN-HldSE–treated FDD mice revealed that GLP-1 signaling was essential for maintaining gut barrier integrity and microbial defense pathways during DSS colitis.